concluded that KMT2C likely acts as a tumor suppressor to limit Myc-driven hepatocellular carcinomas, identifying multiple tumor suppressor programs regulated by KMT2C including cell-autonomous mechanisms (cellular metabolism) and non-autonomous mechanisms (interactions with the extracellular matrix and the immune system) (69). Here, MYC is linked to neoplasm.